Zendy
Open Access
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19
Jama Internal MedicinePeer ReviewedAlex C. Spyropoulos +682021Journals
Hospitalized patients with COVID-19 are at risk for venous and arterial thromboembolism and death. Optimal thromboprophylaxis dosing in high-risk patients is unknown.

The content you want is available to Zendy users.

Already have an account? Sign in
Having issues? Contact support